创新药，大消息！又有新指数来了

Core Insights - The China Securities Index Co., Ltd. will officially launch the China Securities Innovation Drug Index and the China Securities Medical Device Index on November 7, providing richer investment targets for the market [1] Group 1: Innovation Drug Index - The China Securities Innovation Drug Index selects listed companies involved in innovative drug research and development, as well as those providing drug research, development, and production services from the Sci-Tech Innovation Board and the Growth Enterprise Market [4] - A total of 50 constituent stocks have been included in the index, such as BeiGene, Boli Tianheng, Kanglong Chemical, and Zhifei Biological [4] - The innovative drug sector has attracted significant investor attention this year, with China's innovative drug pipeline and clinical trial projects ranking among the top globally [4] Group 2: Medical Device Index - The China Securities Medical Device Index selects listed companies that provide medical devices, consumables, and in vitro diagnostic products and services from the Sci-Tech Innovation Board and the Growth Enterprise Market [4] - 50 constituent stocks have been included in this index, including Mindray Medical, United Imaging, New Industry, and Aimeike [4] - The domestic medical device industry is experiencing rapid development, with a positive outlook on innovation-driven import substitution and global expansion [5]